Cherry Antacid Tablets Recalled for CGMP Deviations
ULTRAtab Laboratories is recalling Cherry Antacid Tablets (Calcium Carbonate 420 mg) in bulk containers due to Current Good Manufacturing Practice (CGMP) deviations. The FDA classified this as a Class II recall.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as a Class II recall for CGMP deviations. The source text does not report any illnesses, injuries, or confirmed product quality failures—only manufacturing process violations. This qualifies as a moderate-severity precautionary recall.
Plain-English summary
ULTRAtab Laboratories, Inc., located in Highland, New York, is voluntarily recalling Cherry Antacid Tablets (Calcium Carbonate 420 mg) distributed in bulk containers. The recall affects approximately 3,052,313 tablets with product code M304 and bulk lots 18K059, 18L106, 18L117, 18M067, and 18M068 (NDC 62959-304-00).
The recall was initiated because the manufacturer identified Current Good Manufacturing Practice (CGMP) deviations during production. The FDA classified this as a Class II recall on February 9, 2022, and the firm voluntarily initiated the recall on January 26, 2022.
The bulk product was distributed to three distributors, who may have further distributed finished products. Consumers who have purchased these antacid tablets should stop using the product. Healthcare providers and distributors who received this product should contact their suppliers for instructions on return or disposal. The recall was terminated on January 7, 2025.
The recalled product
- Product
- Cherry Antacid Tablet (Calcium Carbonate 420 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-304-00
- Manufacturer
- ULTRAtab Laboratories, Inc.
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Product Codes: M304 Bulk Lots: 18K059
- 18L106
- 18L117
- 18M067
- 18M068
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27